The present invention relates generally to sterilization, and more particularly to method and apparatus for sterilization of medical instruments and devices by ultraviolet radiation.
Sterilization of medical instruments and devices (in particular, surgical instruments) is a critical process for medical procedures; for example, newly-manufactured surgical instruments need to be sterilized prior to their first use, and previously-used surgical instruments need to be sterilized prior to their next use. Surgical instrument sterilizers based on various operating principles are currently available; examples include gamma radiation sterilizers, gas-based sterilizers, and steam-based autoclave sterilizers. Each of these has specific advantages and disadvantages.
Gamma radiation sterilizers, for example, can be effective; however, they are expensive and require long process times. Other surgical instrument sterilizers operate at room temperature and use various gases for sterilization. They have the disadvantages of long process times (typically at least 30 to 60 minutes), limited effectiveness for instruments with internal volumes (lumens), and degradation of some materials; furthermore, in addition to electric power, these systems require vacuum pumps. The ethylene oxide (ETO) sterilizer has a cycle time of 15 hours, is explosive and poisonous, and is outlawed in some states. Most of the currently deployed central processing systems use vaporized hydrogen peroxide (VH2O2); some use a combination of ozone (O3) and water vapor (H2O) or a combination of O3 and VH2O2. A combination of O3 and a hydrocarbon derivative such as isopropyl alcohol can shorten the cycle time to approximately two minutes; at least two cycles are needed to meet United States Food and Drug Administration (FDA) requirements.
In steam autoclaves, surgical instruments are sterilized with pressurized steam, typically at a temperature of 121° C. Steam autoclaves can sterilize instruments with external surfaces only (“coupon devices”) as well as those with internal volumes that have openings to the outside (“lumen devices”). The sterilization time itself can be as short as six minutes, but the complete process (including double wrapping the instruments with linen, warm-up, steam sterilization, cool-down, and unwrapping) takes about an hour. The steam process can also produce damage or compromise the sharpness of some instruments and thereby requires periodic steps to restore them. Furthermore, in addition to electric power, steam autoclaves require a water supply and plumbing for the water disposal. Nevertheless, despite these drawbacks, steam autoclaves are the most common sterilizer in use.
Fast effective sterilization would be advantageous to improve productivity and to provide low sterilization cost per instrument cycle. In many circumstances in a hospital, it would also be highly desirable to fully sterilize in minutes a compromised surgical instrument for emergency use during surgery. A similar procedure is also advantageous for sterilizing laboratory instruments. Such expedited capability, known as “flash sterilization”, is currently available only with steam autoclaves operated with unwrapped instruments at a temperature of 132° C., as illustrated in Table 1 below.
Unwrapped instruments, therefore, can be sterilized at an elevated temperature of 132° C. with a 3-minute sterilization cycle; including time for warm-up and cool-down, flash sterilization with a steam autoclave has a full process cycle of typically 6-9 minutes. This process, however, has the potential serious deficiency that the sterilization of the instrument may be compromised by handling without wrapping and by exposure to room air, which is never sterile.
The instrument is certainly no longer totally free of contamination by the time it reaches the surgeon's hands. Flash sterilization is considered to be an emergency procedure for pathogen-compromised, surgical instruments, although often it is used in non-emergency situations as a money-saving shortcut. The high process temperature, furthermore, can shorten the lifetime of the instrument and increase the frequency for maintenance.
Even with wrapped instruments, there are still issues with maintaining with absolute certainty the sterility of the instrument in the pouch or kit until use. The packaging itself, for example, can become contaminated. In surgical practice, it is common for unused instruments to be returned from an operating room to a sterile storage room many times. The outside of the package can become contaminated by blood, for example, in the operating room. Contaminants on the outside of the package can then contaminate the instrument when the package is finally opened for use. Some packages, such as the common sterile wrap-and-peel pouch, can become frayed through repeated handling, and the integrity of the packaging can become compromised.
Most surgical instruments are handled before they get into the surgeon's hands. Instruments are routinely handled in the process of removal from the sterilization system, followed by placement in a sterile pouch that is then sealed or followed by placement in an instrument kit that is then closed. These procedures can compromise sterility. Instruments can become contaminated from pathogens in the air or on gloves. By the time the sterilized surgical instrument is placed in the surgeon's hands for use, its sterility can be assumed to be compromised. Maintaining sterility is critical for surgery: open surgical sites can become infected by as few as 10 pathogens.
In an embodiment of the invention, an object is sterilized with ultraviolet-C radiation having a wavelength from about 235 nm to about 295 nm. The object is inserted into a container, which is then sealed. At least a portion of the container is substantially transparent to ultraviolet-C radiation having a wavelength from about 235 nm to about 295 nm. The container and object are then irradiated for an exposure time with ultraviolet-C radiation having a wavelength from about 235 nm to about 295 nm and having a predetermined intensity. The exposure time is determined such that a predetermined portion of user-specified pathogens disposed on the object prior to irradiation is inactivated. In an embodiment, the wavelength of the UV-C radiation is about 253.7 nm.
In an embodiment of the invention, the container is a flexible pouch fabricated from a material substantially transparent to ultraviolet-C radiation having a wavelength from about 235 nm to about 295 nm. Suitable materials include cyclic olefin copolymer and fluoropolymer. The pouch can be sealed with an adhesive or by thermal fusion. The pouch can also be mechanically sealed.
In an embodiment of the invention, the container is a rigid kit including a receptacle and a cover. The receptacle includes a receptacle plate fabricated from a material substantially transparent to ultraviolet-C radiation having a wavelength from about 235 nm to about 295 nm, a side wall sealed to the receptacle plate, and a receptacle opening opposed to the receptacle plate. The cover includes a cover plate fabricated from a material substantially transparent to ultraviolet-C radiation having a wavelength from about 235 nm to about 295 nm. The cover is configured to mechanically seal the receptacle opening such that the cover plate is opposed to the receptacle plate. Suitable materials for the receptacle plate and the cover plate include quartz, borosilicate glass, and fluoropolymer.
In an embodiment of the invention, the container is a rigid kit including a receptacle and a cover. The receptacle includes a first receptacle plate, a second receptacle plate opposed to the first receptacle plate, a side wall sealed to the first receptacle plate and to the second receptacle plate, and a receptacle opening opposed to a portion of the side wall. The first receptacle plate is fabricated from a material substantially transparent to ultraviolet-C radiation having a wavelength from about 235 nm to about 295 nm. The second receptacle plate is fabricated from a material substantially transparent to ultraviolet-C radiation having a wavelength from about 235 nm to about 295 nm. The cover is configured to mechanically seal the receptacle opening. Suitable materials for the first receptacle plate and the second receptacle plate include quartz, borosilicate glass, and fluoropolymer.
These and other advantages of the invention will be apparent to those of ordinary skill in the art by reference to the following detailed description and the accompanying drawings.
Ultraviolet irradiation in a specific range of wavelengths (discussed below) can be used to inactivate all pathogen types including, for example, anthrax and C. difficile endospores, S. aureus (antibiotic forms are also known as MRSA), smallpox, viral hemorrhagic fevers, pneumonic plague, glanders, tularemia, and drug-resistant tuberculosis. Pathogens that have a relatively thick cell wall, such as endospores, are more resistant to ultraviolet irradiation because the thick cell wall transmits less ultraviolet radiation; consequently, the ultraviolet radiation intensity inside the cell wall is reduced. With higher intensities or longer exposure times (or a combination of both higher intensities and longer exposure times), however, even the most resistant endospores are readily inactivated by ultraviolet irradiation.
The effectiveness of ultraviolet irradiation derives primarily from a narrow band of ultraviolet-C (UV-C) radiation about 60 nm wide centered at a wavelength of about 260 nm; that is, wavelengths ranging from about 235 nm to about 295 nm. The UV-C radiation in that particular band acts by eliminating the ability of any given pathogen to reproduce through mitosis and potentially cause an infection. Eliminating the ability to undergo mitosis is called inactivation.
Radiation intensity is a measure of radiant power incident per unit area. If a pathogen is in the presence of UV-C radiation of a given wavelength for a given exposure time, the integral of the radiation intensity received by the pathogen over time determines the radiant energy exposure per unit area. The surface area of the pathogen defines the actual energy incident on and passing through the pathogen. Statistically the incident photons passing through the pathogen have a reasonable probability of being absorbed by a particular DNA molecule within the pathogen, breaking certain bonds within the DNA molecule. The DNA molecule loses its ability to trigger mitosis in the pathogen, and the pathogen loses its ability to multiply and cause infection; hence, the process causes inactivation of the pathogen.
The percentage reduction of pathogens of any given specific type depends on the integrated product of the UV-C radiant intensity incident on the pathogen and the exposure time. This product is typically called “the applied dose” . The energy per unit area incident on a distribution of identical pathogens needed to achieve a reduction in ability to undergo mitosis by a factor of 10 (alternatively, to inactivate 90% of the pathogens in the distribution) is frequently called the LD90. The value of LD90, for a specific pathogen, depends on the wavelength or range of wavelengths. If the applied dose is , and equals Θ times LD90, then the reduction in the number of viable pathogens as a result of exposure is 10−Θ.
Herein, “sterilization” refers generically to a process for inactivating pathogens. “Technical sanitation” is defined as Θ=4, a reduction in the number of viable pathogens to 10−4 of the initial number of viable pathogens (alternatively, to inactivate 99.99% of the pathogens in the distribution). It requires application of a radiant energy per unit area equal to 4 times LD90. “Technical sterilization” corresponds to Θ=6 (alternatively, to inactivate 99.9999% of the pathogens in the distribution).
The UV-C output radiation of interest can be excited, for example, by a discharge in a low-pressure argon gas containing mercury vapor; the emitted wavelengths are centered at 253.7 nm. The gas is contained in a discharge tube; the discharge tube wall, typically made of special quartz, is highly transmissive for the wavelengths of interest. As described below, in embodiments of a UV-C source, tubes with a nominal surface emission intensity of about 250 watts/m2 at the tube surface can produce a uniform, isotropic intensity in an UV-C exposure chamber of about 500 watts/m2. For a wavelength of 253.7 nm, a surface applied dose on the order of 1200 joules/m2 is adequate to achieve technical sterilization for all pathogens of interest in a hospital, laboratory, or food-preparation environment. Other sources emitting UV-C radiation in a range (band) of wavelengths near 253.7 nm include xenon lamps and light-emitting diodes.
As shown in
Refer to
The partition 120 and the partition 122 are fabricated from material, or materials, substantially transparent to UV-C radiation; suitable materials are discussed below. The partition 120 and the partition 122 can be fabricated from the same material or from different materials. The partition 120 and the partition 122 can have the same thickness (measured along the Y-axis) or different thicknesses. The partition 120 prevents contact with the UV-C source 130, and the partition 122 prevents contact with the UV-C source 132. The partition 122, furthermore, serves as a support shelf on which objects to be sterilized can be placed. The partition 120, therefore, can be thinner and more flexible than the partition 122. As discussed below, other configurations of ultraviolet irradiation devices can be used.
In operation, the door 104 is opened, and the object to be sterilized is placed into the UV-C exposure chamber 140 on the partition 122. The door 104 is then closed, and the UV-C source 130 and the UV-C source 132 are activated for a predetermined exposure time. The door 104 is then opened, and the object is removed.
In an embodiment of the invention, the object to be sterilized is first sealed in a container. The container is fabricated from material, or materials, that are substantially impermeable to pathogens of interest (these pathogens, for example, are specified by applicable medical standards). The seal is also substantially impermeable to the transmission of pathogens. At least a portion of the container is fabricated from material, or materials, that are also substantially transparent to UV-C radiation. Suitable materials are discussed below.
A container can be either flexible or rigid. Herein, a flexible container is referred to as a “pouch” and a rigid container is referred to as a “kit”. A pouch for containing a medical instrument (in particular, a surgical instrument) is referred to as an “instrument pouch”, and a kit for containing a medical instrument is referred to as an “instrument kit”.
Other configurations of pouches can be used.
Various methods can be used to seal a pouch. Single-use (disposable) pouches, for example, can be sealed with adhesive or by thermal fusion. For multi-use (reusable) pouches, a mechanical seal can be used.
The kit 400 includes the receptacle 402 and the cover 404. In the embodiment shown in
The receptacle 402 includes the side wall 410 and the bottom plate 420. As shown, the side wall is flat and oriented orthogonal to the bottom plate. In general, the side wall can be flat or curved and can be oriented non-parallel to the bottom plate. The bottom plate 420 is fabricated from material, or materials, substantially transparent to UV-C radiation. In some embodiments, the side wall is also fabricated from material, or materials, substantially transparent to UV-C radiation. In other embodiments, the interior surface 412 (in part or in entirety) of the side wall is fabricated from a material, such as aluminum, having substantially high reflectivity for UV-C radiation. For example, the side wall 410 can be fabricated from sheet aluminum; or the side wall 410 can be fabricated from plastic, and the interior surface 412 can be coated with aluminum film.
The cover 404 includes the side wall 440 and the top plate 450. As shown, the side wall is flat and oriented orthogonal to the top plate. In general, the side wall can be flat or curved and can be oriented non-parallel to the top plate. Both the side wall 440 and the top plate 450 are fabricated from material, or materials, substantially transparent to UV-C radiation.
The cover 450A is a circular plate fabricated from material, or materials, substantially transparent to UV-C radiation. In the embodiment shown in
In some embodiments, the side wall is also fabricated from material, or materials, substantially transparent to UV-C radiation. In other embodiments, the interior surface 412A (in part or in entirety) of the side wall is fabricated from a material, such as aluminum, having a substantially high reflectivity for UV-C radiation. For example, the side wall 410A can be fabricated from sheet aluminum; or the side wall 410A can be fabricated from plastic, and the interior surface 412A can be coated with aluminum film. In some embodiments, the receptacle 402A is fabricated from several pieces sealed together. In other embodiments, the receptacle 402A is fabricated as a single piece.
The cover and the receptacle can be mechanically sealed together. In the embodiment shown in
The top plate 470 and the bottom plate 472 are fabricated from material, or materials, substantially transparent to UV-C radiation; the top plate 470 and the bottom plate 472 can be fabricated from the same material or from different materials. In some embodiments, the side wall is also fabricated from material, or materials, substantially transparent to UV-C radiation. In other embodiments, the interior surface 464 (in part or in entirety) of the side wall is fabricated from a material, such as aluminum, having a substantially high reflectivity for UV-C radiation. For example, the side wall 462 can be fabricated from sheet aluminum; or the side wall 462 can be fabricated from plastic, and the interior surface 464 can be coated with aluminum film.
Refer back to
The cover and the receptacle can be mechanically sealed together. In the embodiment shown in
Quartz, due to its high UV-C transmission, is advantageous for the envelope of a UV-C lamp emitting at a wavelength λ=253.7 nm. Borosilicate glass, not shown, can have >80% transmission at λ=253.7 nm for a thickness of 2 mm and can also be used for UV-C tubes (see, for example, U.S. Pat. No. 5,547,904 and U.S. Pat. No. 5,610,108). For quartz, the bulk absorption loss is negligible, and the fact that the transmission factor is not quite 100% results from reflection loss at the two quartz-air interfaces.
Reflection does not actually result in an intensity loss in a UV-C tube, and also not in the ultraviolet irradiation process described herein, because the reflected photons are not lost. Rather, a reflected λ=253.7 nm photon moving back into the tube is absorbed by a ground state mercury atom (because the lower level of the radiating transition is the ground state). The mercury atom is consequently excited to the λ=253.7 nm radiating level which then transitions back to the ground state as it re-emits the photon. The reflected photon is not lost. Hence, these curves underestimate the effective transmission factor. In embodiments of a UV-C source, tubes with a nominal surface emission intensity of about 250 watts/m2 at the tube surface produce a uniform, isotropic intensity in the UV-C exposure chamber of about 500 watts/m2.
Quartz and low-loss borosilicate glass can also be used for the partition 120 and the partition 122 in the ultraviolet irradiation device 100 (
Quartz and low-loss borosilicate glass are rigid materials and are therefore not suitable materials for a pouch. A pouch could be made of PMMA, but its transmission loss would be high. An advantageous choice of pouch material is TOPAS Cyclic Olefin Copolymer (TOPAS COC), or variations thereof, which has good physical properties and is used for packaging medical devices, medicines, and food. (For information on TOPAS COC, see “TOPAS Cyclic Olefin Copolymer (COC)”, pp. 1-20, Topas Advanced Polymers GmbH, Frankfurt, Germany, and Topas Advanced Polymers, Inc., Florence, Ky., USA, March 2006.) In particular, TOPAS COC 8007X10 has a UV-C transmission at τ=253.7 nm of about 20% in a 2-mm thickness as shown in plot 204. The percent transmission factor at τ=253.7 nm, {hacek over (T)} (λ=253.7 nm) in %, as a function of the thickness of the TOPAS COC 8007X10, τ, in mm, is given by the Beer-Lambert Law, in which the parameter 0.8045 is determined from the plot 204 with τ=2 mm: {hacek over (T)} (λ=253.7 nm)=100 exp(−0.8045 τ). From the Beer-Lambert Law, the following values are obtained (1 mil=0.001 inch):
Reflection loss will reduce the 4-mil value by about 8% to about {hacek over (T)}≈80%, but does not increase the actual intensity loss in the application of interest (pouch for UV-C irradiation). In a direct transmission measurement at λ=253.7 nm, for a 4-mil thick film of TOPAS COC 8007X10, it was determined that {hacek over (T)}=90% with reflection loss. A disadvantage of TOPAS COC 8007X10 is that it degrades under UV-C irradiation; that is, the transmission loss increases with repeated UV-C exposure. The relatively low cost of TOPAS COC 8007X10, however, makes it well suited for single-use, disposable pouches (
Another advantageous material for containers is Teflon AF, a fluoropolymer. (For information on Teflon AF, see M. K. Yang et al., “Optical properties of Teflon AF amorphous fluoropolymers”, J. Micro/Nanolith. MEMS MOEMS 7(3), 033010 (July-September 2008), pp. 033010-1 to 033010-9, and references cited therein.) Teflon AF is strong, durable, and commercially available in pliable thin films and rigid sheets. It has optical transmission characteristics similar to that of UV-C transparent quartz. The transmission factor is limited only by reflection and not by loss. Moreover, Teflon AF does not degrade when exposed to UV-C radiation. Although it can be used for single-use, disposable pouches, it is substantially more expensive than TOPAS COC. Pliable thin films of Teflon AF, therefore, are well suited for multi-use (reusable) pouches (see FIG. J-
In practice, a material is substantially transparent to UV-C radiation according to the following criteria. Assume that a sheet or film of the material with a specified thickness is placed between a UV-C source and a surface contaminated with pathogens. Assume that the UV-C intensity incident on the sheet or film has a specified value. The UV-C intensity incident on the surface contaminated with pathogens depends on the UV-C intensity incident on the sheet or film and the transmission loss in the sheet or film. The material is substantially transparent to UV-C radiation if a specified portion of the pathogens disposed on the surface of the object is inactivated within a specified exposure time. For example, for technical sterilization, with a UV-C wavelength of about 253.7 nm and a UV-C intensity incident on the sheet or film of about 500 watts/m2, 99.9999% of pathogens of interest can be inactivated within an exposure time on the order of seconds. For example, C. difficile, with an LD90 value of 200 joules/m2, requires an exposure time of about 2.4 sec for technical sterilization; and anthrax, with an LD90 value of 750 joules/m2, requires an exposure time of about 9 sec.
In
In
In an embodiment of the invention, radio-frequency identification (RFID) tags are attached to pouches, kits, and ultraviolet irradiation devices. A control system can determine whether a specific pouch or a specific kit is compatible with a specific ultraviolet irradiation device. If the control system determines that a specific pouch or specific kit is not compatible with a specific ultraviolet irradiation device, it can send a notification (for example, via an audible alarm or via a flashing indicator) to the operator; the control system can also prevent the UV-C sources from being activated.
All current sterilizers require periodic testing with a biological indicator (BI) to certify that the sterilization process actually achieves sterilization of a particular test endospore. A conventional biological indicator includes a vial containing test pathogens. The biological indicator is processed along with the object to be sterilized. Full technical sterilization certification with a biological indicator requires approximately 24 hours or more; hence, it is not done with every load. The systems do require a process indicator (PI) with each load. The process indicator indicates that the technical sterilization process was fully executed but does not guarantee that technical sterilization was actually achieved.
In an embodiment of the invention, a biological indicator for UV-C sterilization includes a closed vial containing test pathogens; the closed vial is fabricated from material, or materials, substantially transparent to UV-C radiation. The closed vial is placed in the UV-C exposure chamber along with the pouch or kit containing the object to be sterilized.
In an embodiment of the invention, a process indicator is used to monitor operation of the ultraviolet irradiation device. A substrate coated with special phosphors is placed within the pouch or kit, along with the object to be sterilized. The substrate, for example, can be a small quartz disc. When the phosphors are irradiated with UV-C radiation, the phosphors produce long-lived, narrow-band, visible light photo-luminescence. Suitable phosphors include those used in conventional fluorescent lamps. A typical “cool white” fluorescent lamp utilizes two rare earth doped phosphors, Tb3+, Ce3+: LaPO4, for green and blue emission. The intensity of the photo-luminescence is a measure of the total UV-C dose delivered to the interior of the pouch or kit. A small narrow-band spectrophotometer, such as a photodiode, can be mounted inside the ultraviolet irradiation device. The spectrophotometer measures the photo-luminescence emitted from within the sealed pouch or kit and indicates that a specified UV-C dose has been delivered.
Pathogens are not inactivated on a surface or in a space that is not exposed to UV-C radiation. Surfaces in contact about a pivot and a space within a cavity are typically shielded from UV-C radiation. In some embodiments of the invention, portions of an object are fabricated from material, or materials, substantially transparent to UV-C radiation such that all surfaces (external and internal) on the object and all spaces within the object are exposed to UV-C radiation. In other embodiments of the invention, an object is fabricated entirely of material, or materials, substantially transparent to UV-C radiation.
Refer to
In an embodiment of the invention, at least a portion of the arm 702A about the pivot hole 705A and at least a portion of the arm 702B about the pivot hole 705B are fabricated from material, or materials, substantially transparent to UV-C radiation. In addition, the pivot 710 can be fabricated from material, or materials, substantially transparent to UV-C radiation.
In medical instruments or devices, the tubular structure 802 is typically fabricated from a material that shields at least a portion of the interior surface 801B and at least a portion of the lumen 803 from UV-C radiation. In an embodiment of the invention, the tubular structure 802 is fabricated from material, or materials, substantially transparent to UV-C radiation.
In an embodiment of the invention, other medical supplies, such as sutures (also referred to as suture thread) are fabricated from material, or materials substantially transparent to UV-C radiation such that all portions of the medical supply can be sterilized by UV-C irradiation.
The UV-C irradiation process described above for sterilization of instruments can be advantageously combined with other sterilization processes. Some examples are described below.
The ultraviolet irradiation devices described above can process sterilized, coupon instruments (instruments without lumens) in seconds (total start-to-finish). In an embodiment of the invention, an ultraviolet irradiation device is used in combination with a UV-C hand sterilizer (as described in U.S. Pat. No. 8,142,713). The instrument is not sealed in a pouch or kit; it is placed directly into an ultraviolet irradiation device. An operator wears a glove on his hand, sterilizes the glove with the UV-C hand sterilizer, removes the sterilized instrument from the ultraviolet irradiation device, and hands the sterilized instrument directly to a surgeon, who is also wearing a freshly-sterilized glove. Technical sterilization can be achieved with this process.
Autoclaves can sterilize instruments with lumens since the high temperatures will inactivate the pathogens within the lumen. Autoclaves, furthermore, will sterilize an instrument even when there is a layer of dirt covering live pathogens, since the layer does not block the heat from inactivating all the pathogens. In conventional autoclave processing, warm-up, wrapping, cool-down, and unwrapping take considerable time. Eliminating the wrapping and unwrapping steps can reduce the total autoclave sterilization cycle time to approximately 6 minutes. After autoclave sterilization, however, the surfaces of the instrument can become contaminated through improper handling by the operator or through contact with contaminated room air.
In an embodiment of the invention, the UV-C sterilization process described above is used in combination with autoclave sterilization process. For example, lumen-type instruments without wrapping are first sterilized with a 6-minute cycle, autoclave sterilization process, sealed in a pouch substantially transparent to UV-C radiation, and then surface sterilized with UV-C radiation. Technical sterilization can be achieved with this process.
UV-C sterilization can also be applied advantageously to the production of sterile surgical gloves. Producing surgical gloves that are always sterile when they are removed from the package is a manufacturing challenge and is costly. Currently, sterility of the delivered surgical glove cannot be assured; there is always a small component of the product that is not sterile. The manufacturing process for sterile surgical gloves is not under good control and an uncharacterized fraction of the gloves is not sterile upon removal from their package at the time of use. The manufacturing process can lead to variability in the fraction that is not sterile, depending on the time and conditions under which they are manufactured. Furthermore, the manufacturing process used to semi-reliably achieve sterility adds significantly to the cost of manufacture. Exam gloves are typically not sterile, no attempt is made to achieve sterility, and their cost is substantially less. The only goal of the exam glove is to protect the wearer and that does not require sterility.
In an embodiment of the invention, UV-C sterilization is applied to the manufacture of sterile surgical gloves; the process can produce gloves that are guaranteed sterile in the package. A sealed pouch, substantially-transparent to UV-C radiation, containing one glove or a pair of gloves is subjected during manufacture to UV-C sterilization as described above. In an embodiment, the package is made of TOPAS COC, 1-2 mils thick. The UV-C transmission is virtually 100%, and the TOPAS COC material is sturdy.
Production includes a close-to-final step in which the sealed pouch, containing the glove or gloves, is irradiated as it travels within a high intensity UV-C irradiation tunnel with a total dose sufficient to sterilize with certainty; technical sterilization can be achieved with this process. This process would reduce the cost of producing and packaging a sterile glove and essentially would guarantee sterility as it comes out of the package. In an embodiment of the invention, surgical gloves are fabricated from material, or materials (such as TOPAS COC or Teflon AF), substantially transparent to UV-C radiation.
The above description has focused on UV-C sterilization of surgical instruments. As discussed above, however, an arbitrary “object” can be sterilized with UV-C irradiation. Objects include other medical instruments and devices such as dental instruments, stethoscopes, and cuffs for blood pressure gauges. Objects also include non-medical objects such as eating utensils, food-preparation equipment, and common objects such as toys and cell phones that can be a source of infection. In applications that do not require technical sterilization, the applied UV-C dose can be adjusted to provide a specified percentage of pathogen inactivation.
The foregoing Detailed Description is to be understood as being in every respect illustrative and exemplary, but not restrictive, and the scope of the invention disclosed herein is not to be determined from the Detailed Description, but rather from the claims as interpreted according to the full breadth permitted by the patent laws. It is to be understood that the embodiments shown and described herein are only illustrative of the principles of the present invention and that various modifications may be implemented by those skilled in the art without departing from the scope and spirit of the invention. Those skilled in the art could implement various other feature combinations without departing from the scope and spirit of the invention.
This application claims the benefit of U.S. Provisional Application No. 61/537,731 filed Sep. 22, 2011, which is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
61537731 | Sep 2011 | US |